Hessen Eline D, van Buuren Laurens D, Nijkamp Jasper A, de Vries Kim C, Kong Mok Wai, Dewit Luc, van Mourik Anke M, Berlin Alejandro, van der Heide Uulke A, Borst Gerben R
Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Clin Transl Radiat Oncol. 2017 Jan 26;2:23-28. doi: 10.1016/j.ctro.2016.12.007. eCollection 2017 Feb.
Linac-based stereotactic radiosurgery (SRS) for brain metastases may be influenced by the time interval between treatment preparation and delivery, related to risk of anatomical changes. We studied tumor position shifts and its relations to peritumoral volume edema changes over time, as seen on MRI.
Twenty-six patients who underwent SRS for brain metastases in our institution were included. We evaluated the occurrence of a tumor shift between the diagnostic MRI and radiotherapy planning MRI. For 42 brain metastases the tumor and peritumoral edema were delineated on the contrast enhanced T1weighted and FLAIR images of both the diagnostic MRI and planning MRI examinations. Centre of Mass (CoM) shifts and tumor borders were evaluated. We evaluated the influence of steroids on peritumoral edema and tumor volume and the correlation with CoM and tumor border changes.
The median values of the CoM shifts and of the maximum distances between the tumor borders obtained from the diagnostic MRI and radiotherapy planning MRI were 1.3 mm (maximum shift of 5.0 mm) and 1.9 mm (maximum distance of 7.4 mm), respectively. We found significant correlations between the absolute change in edema volume and the tumor shift of the CoM ( < 0.001) and tumor border ( = 0.040). Patients who received steroids did not only had a decrease in peritumoral edema, but also had a median decrease in tumor volume of 0.02 cc while patients who did not receive steroids had a median increase of 0.06 cc in tumor volume ( = 0.035).
Our results show that large tumor shifts of brain metastases can occur over time. Because shifts may have a significant impact on the local dose coverage, we recommend minimizing the time between treatment preparation and delivery for Linac based SRS.
基于直线加速器的立体定向放射外科治疗(SRS)用于脑转移瘤时,可能会受到治疗准备与实施之间时间间隔的影响,这与解剖结构变化的风险有关。我们研究了肿瘤位置随时间的变化及其与瘤周体积水肿变化的关系,这些变化可通过磁共振成像(MRI)观察到。
纳入了在我们机构接受SRS治疗脑转移瘤的26例患者。我们评估了诊断性MRI与放射治疗计划MRI之间肿瘤移位的发生情况。对于42个脑转移瘤,在诊断性MRI和计划MRI检查的对比增强T1加权像和液体衰减反转恢复(FLAIR)像上勾勒出肿瘤和瘤周水肿。评估了质心(CoM)移位和肿瘤边界。我们评估了类固醇对瘤周水肿和肿瘤体积的影响以及与CoM和肿瘤边界变化的相关性。
从诊断性MRI和放射治疗计划MRI获得的CoM移位的中位数以及肿瘤边界之间的最大距离分别为1.3毫米(最大移位5.0毫米)和1.9毫米(最大距离7.4毫米)。我们发现水肿体积的绝对变化与CoM的肿瘤移位(<0.001)和肿瘤边界(=0.040)之间存在显著相关性。接受类固醇治疗的患者不仅瘤周水肿减少,而且肿瘤体积中位数减少0.02立方厘米,而未接受类固醇治疗的患者肿瘤体积中位数增加0.06立方厘米(=0.035)。
我们的结果表明,脑转移瘤随时间可能会发生较大的肿瘤移位。由于移位可能对局部剂量覆盖有重大影响,我们建议尽量缩短基于直线加速器的SRS治疗准备与实施之间的时间。